Numan Fateh, DO
Hematology & Oncology · Clarkston, MINPI 1619262276
Payments from drug & device makers
Across 31 payments — averaging $20.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$147
- Novartis$91
- E.r. Squibb & Sons, L.L.C.$72
- Bristol Myers Squibb$39
- GSK$38
- Servier Pharmaceuticals LLC$34
- plus $204 from 9 others
What the payments were for
- Food & beverage$625100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 7 | $147 |
| Novartis | 4 | $91 |
| E.r. Squibb & Sons, L.L.C. | 4 | $72 |
| Bristol Myers Squibb | 1 | $39 |
| GSK | 2 | $38 |
| Servier Pharmaceuticals LLC | 2 | $34 |
| Ipsen Biopharmaceuticals, Inc | 2 | $34 |
| Johnson & Johnson | 2 | $34 |
| Sanofi | 1 | $29 |
| AstraZeneca | 1 | $21 |
| Beone Medicines USA, Inc. | 1 | $20 |
| Tolmar Pharmaceuticals, Inc. | 1 | $19 |
| AVEO Pharmaceuticals, Inc. | 1 | $17 |
| Myriad Genetic Laboratories, Inc. | 1 | $17 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $13 |
How this compares
$625 in reported general payments places this provider in the 25th percentile of 282 hematology & oncology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 36 | $28,747 |
| Anastrozole | 62 | $3,246 |
| Hydroxyurea | 15 | $924 |
| Oxycodone Hcl | 42 | $833 |
| Letrozole | 27 | $431 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $262 |
| Ondansetron Hcl | 12 | $137 |
| Gabapentin | 12 | $60 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Clarkston
- Sreenivasa ChandanaGrand Rapids$19.1M
- Nehal LakhaniGrand Rapids$15M
- Hirva MamdaniDetroit$9.5M
- Jeffrey ZonderDetroit$8.2M
- Assuntina SaccoAnn Arbor$8.1M
- Abhinav DeolDetroit$4.5M
- Harsh ShahDetroit$2.6M
- Igor RybkinDetroit$2.4M
- Jason BrownAnn Arbor$2.3M
- Brett BrinkerGrand Rapids$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.